TrivarX Limited
MDBIF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $20 | $2 | $7 | $7 |
| - Cash | $1 | $1 | $1 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $19 | $1 | $6 | $6 |
| Revenue | $0 | $1 | $1 | $0 |
| % Growth | -100% | 29.8% | 3,965.7% | – |
| Gross Profit | $0 | $1 | -$0 | -$0 |
| % Margin | 6,506.8% | 98.4% | -5.3% | -174% |
| EBITDA | -$1 | -$0 | -$1 | -$1 |
| % Margin | -296,368% | -2.9% | -112.4% | -4,801.6% |
| Net Income | -$1 | -$0 | -$0 | -$1 |
| % Margin | -306,528.1% | -8.1% | -17.4% | -5,074.6% |
| EPS Diluted | -0.002 | -0 | -0.001 | -0.004 |
| % Growth | -700% | 60% | 85.7% | – |
| Operating Cash Flow | -$1 | $0 | $1 | -$1 |
| Capital Expenditures | $0 | $0 | -$1 | -$1 |
| Free Cash Flow | -$1 | $0 | -$1 | -$3 |